Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
US FDA Plans More Sentinel Growth, But Industry Questions Paying With User Fees
Dec 18 2025
•
By
Derrick Gingery
The Sentinel 3.0 plan would enhance FDA drug safety surveillance.
(Shutterstock)
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from User Fees
More from United States